Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer

Class:Id	LiteratureReference:9925060
_displayName	PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer
_timestamp	2024-10-16 18:46:36
author	[Person:9925228] Rostami, Fatemeh [Person:9925218] Tavakol Hamedani, Zahra [Person:9925160] Sadoughi, Azadeh [Person:9925325] Mehrabadi, Marzieh [Person:9925154] Kouhkan, Fatemeh
created	[InstanceEdit:9925315] Tiwari, Krishna, 2024-10-16
journal	Sci Rep
modified	[InstanceEdit:9925426] Tiwari, Krishna, 2024-10-16
pages	13542
pubMedIdentifier	38866824
title	PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer
volume	14
year	2024
(literatureReference)	[Reaction:9925087] CD274 mRNA binds miR-138-5p RISC [Homo sapiens] [RegulationReference:9925054] Negative regulation by 'CD274 mRNA:miR-138-5p RISC [cytosol]' PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer [Summation:9925117] MicroRNA 138 5p (miR-429-5p) plays a role in immune checkpoi...
[Change default viewing format]

No pathways have been reviewed or authored by PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer (9925060)